Screening for diabetic retinopathy

Diabetic Retinopathy: Evidence-Based Management

Volumn , Issue , 2010, Pages 369-385

  Browning, David J ^a  

^a Charlotte Eye Ear Nose and Throat Associates   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84892269862     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-0-387-85900-2_14     Document Type: Chapter

References (97)

1. Jekel JF, Elmore JG, Katz DL. Epidemiology, Biostatis-tics, and Preventive Medicine. 1st ed. Philadelphia: WB Saunders; 1996:216-217.
2. Leiter LA, Barr A, Belanger A, et al. Diabetes screening in Canada (DIASCAN) study. Diabetes Care. 2001;24: 1038-1043.
3. Kuo HK, Hsieh HH, Liu RT. Screening for diabetic retinopathy by one-field, non-mydriatic, 45 degrees digital photography is inadequate. Ophthalmologica. 2005; 219:292-296.
4. Diabetes Control and Complications Trial Research Group. Lifetime benefits and costs of intensive therapy as practiced in the diabetes control and complications trial. JAMA. 1996;276:1409-1415.
5. Lin DY, Blumenkranz MS, Brothers RJ, et al. The sensitivity and specificity of single field nonmydriatic monochromatic digital fundus photography with remote image interpretation for diabetic retinopathy screening: a comparison with ophthalmoscopy and standardized mydriatic color photography. Am J Ophthalmol. 2002; 134:204-213.
6. Tung TH, Shih HC, Chen SJ, et al. Economic evaluation of screening for diabetic retinopathy among Chinese Type 2 diabetics: a community-based study in Kinmen, Taiwan. J Epidemiol. 2008;18:225-233.
7. Vijan S, Hofer TP, Hayward RA. Cost-utility analysis of screening intervals for diabetic retinopathy in patients with type 2 diabetes mellitus. JAMA. 2000;283:889-896.
8. Chew EY, Benson WR, Boldt HC, et al. Diabetic Retino-pathy Preferred Practice Guidelines. San Francisco: American Academy of Ophthalmology; 2003.
9. Liesenfeld B, Kohner E, Piehlmeier W, et al. A telemedi-cine approach to the screening of diabetic retinopathy: digital fundus photography. Diabetes Care. 2000;23: 345-348.
10. Harvey JN, Craney L, Nagendran S, Ng CS. Towards comprehensive population-based screening for diabetic retinopathy: operation of the North Wales diabetic reti-nopathy screening programme using a central patient register and various screening methods. J Med Screen. 2006;13:87-92.
11. Boucher MC, Nguyen QT, Angioi K. Mass community screening for diabetic retinopathy using a nonmydriatic camera with telemedicine. Can J Ophthalmol. 2005;40:734-742.
12. Raman R, Rani PK, Rachepalle SR, et al. Prevalence of diabetic retinopathy in India. Sankara Nethralaya diabetic retinopathy epidemiology and molecular genetics study report 2. Ophthalmology. 2009;116:311-318.
13. McKay R, McCarty CA, Taylor HR. Diabetic retino-pathy in Victoria, Australia: the visual Impairment Project. Br J Ophthalmol. 2000;84:865-870.
14. Roy MS. Eye care in African Americans with type1 Diabetes. The New Jersey 725. Ophthalmology. 2004;111:914-920.
15. Moss SE, Klein R, Klein BE. Factors associated with having eye examinations in persons with diabetes. Arch Fam Med. 1995;4:529-534.
16. Wang F, Javitt J. Eye care for elderly Americans with diabetes mellitus; failure to meet current guidelines. Ophthalmology. 1996;103:1744-1750.
17. Bresnick GH, Mukamel DB, Dickinson JC, Cole DR. A screening approach to the surveillance of patients with diabetes for the presence of vision-threatening retinopa-thy. Ophthalmology. 2000;107:19-24.
18. Sprafka JM, Fritsche TL, Baker R, et al. Prevalence of undiagnosed eye disease in high-risk diabetic individuals. Arch Intern Med. 1990;150:857-861.
19. Wong KC, Wang Z. Prevalence oftype2 diabetes mellitus of Chinese populations in mainland China, Hong Kong, and Taiwan. Diab Res Clin Pract. 2006;73:126-134.
20. Xie XW, Xu L, Wang YX, Jonas JB. Prevalence and associated factors of diabetic retinopathy. The Beijing Eye Study 2006. Graefes Arch Clin Exp Ophthalmol. 2008;246:1519-1526.
21. Farley TF, Mandava N, Prall FR, Carsky C. Accuracy of primary care clinicians in screening for diabetic reti-nopathy using single-image retinal photography. Ann Fam Med. 2008;6:428-434.
22. Clark J, Grey R, Lim K, Burns-Cox C. Loss of vision before ophthalmic referral in blind and partially sighted diabetics in Bristol. Br J Ophthalmol. 1994;78:741-744.
23. Bek T, Lund-Andersen H, Hansen AB, et al. The prevalence of diabetic retinopathy in patients with screen-detected type 2 diabetes in Denmark: the ADDITION study. Acta Ophthalmologica. 2008;E-pub ahead of print.
24. Deb-Joardar N, Germain N, Thuret G, et al. Screening for diabetic retinopathy by ophthalmologists and endo-crinologists with pupillary dilation and a nonmydriatic digital camera. Am J Ophthalmol. 2005;140:814-821.
25. Stefansson E, Bek T, Porta M, et al. Screening and prevention of diabetic blindness. Acta Ophthalmol Scand. 2000;78:374-385.
26. Boucher MC, Desroches G, Garcia-Salinas R, et al. Teleophthalmology screening for diabetic retinopathy through mobile imaging units within Canada. Can J Ophthalmol. 2008;43:658-668.
27. Will JC, German RR, Schurman E, et al. Patient adherence to guidelines for diabetes eye care: results from the Diabetic Eye Disease Follow-up Study. Am J Public Health. 1994;84:1669-1671.
28. Moller F, Hansen M, Sjolie AK. Is one 60 degree fundus photograph sufficient for screening of proliferative diabetic retinopathy? Diabetes Care. 2002;24:2083-2085.
29. Klein R, Klein BEK, Neider MW, et al. Diabetic retino-pathyasdetected using ophthalmoscopy, a nonmydriatic camera and a standard fundus camera. Ophthalmology. 1985;92:486-491.
30. Barrie T, MacCuish AC. Assessment of non-mydriatic fundus photography in detection of diabetic retinopathy. BMJ. 1986;293:1304-1305.
31. von Wendt G, Summanen P, Hallnais K, et al. Detection of diabetic retinopathy: a comparison between red-free digital images and colour transparencies. Graefes Arch Clin Exp Ophthalmol. 2005;243:427-432.
32. James M, Turner DA, Broadbent DM, et al. Cost effectiveness analysis of screening for sight threatening diabetic eye disease. BMJ. 2000;320:1627-1631.
33. Leese GP, Boyle P, Feng Z, et al. Screening uptake in a well-established diabetic retinopathy screening program: the role of geographical access and deprivation. Diabetes Care. 2008;31:2131-2135.
34. Singer DE, Nathan DM, Fogel HA, Schachat AP. Screening for diabetic retinopathy. Ann Intern Med. 1992; 116:660-671.
35. Nathan DM, Fogel HA, Godine JE, et al. Role of the diabetologist in evaluating diabetic retinopathy. Diabetes Care. 1991;14:26-33.
36. Stellingwerf C, Hardus PLLJ, Hooymans MM. Assessing diabetic retinopathy using two-field digital photography and the influence of JPEG-compression. Doc Ophthalmol. 2004;108:203-209.
37. Klein R, Klein BEK, Moss SE, Cruikshanks KJ. The Wisconsin epidemiologic study of diabetic retinopathy. XIV. Ten-year incidence and progression of diabetic retinopathy. Arch Ophthalmol. 1994;112:1217-1228.
38. Klein R, Klein BEK, Moss SE, et al. The Wisconsin epi-demiologic study of diabetic retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol. 1984;102:520-526.
39. Lueder GT, Silverstein J, Section on Ophthalmology, et al. Screening for retinopathy in the pediatric patient with type 1 diabetes mellitus. Pediatrics. 2005;116:270-273.
40. Lueder GT, Pradhan S, White NH. Risk of retinopathy in children with type 1 diabetes mellitus before 2 years of age. Am J Ophthalmol. 2005;140:930-931.
41. Scanlon PH, Foy C, Chen FK. Visual acuity measurement and ocular co-morbidity in diabetic retinopathy screening. Br J Ophthalmol. 2008;92:775-778.
42. Anderson S, Broadbent DM, Swain JYS, et al. Ambulatory photographic screening for diabetic retinopathy in nursing homes. Eye. 2003;17:711-716.
43. Trautner C, Icks A, Haastert B, et al. Incidence of blindness in relation to diabetes. Diabetes Care. 1997;20:1147-1153.
44. Sussman E, Tsiaras W, Soper K. Diagnosis of diabetic eye disease. JAMA. 1982;247:3231-3234.
45. O'Hare JP, Hopper A, Madhaven C, et al. Adding retinal photography to screening for diabetic retinopathy: a prospective study in primary care. BMJ. 1996;312:679-682.
46. Davies R, Sullivan P, Canning C. Simulation of diabetic eye disease to compare screening policies. Br J Ophthal-mol. 1996;80:945-950.
47. Pugh JA, Jacobson JM, Van Heuven WA, et al. Screening for diabetic retinopathy. The wide angle retinal camera. Diabetes Care. 1993;16:889-895.
48. Harding SP, Broadbent DM, Neoh C, et al. Sensitivity and specificity of photography and direct ophthalmoscopy in screening for sight threatening eye disease: the Liverpool Diabetic Eye Study. BMJ. 1995;311:1131-1135.
49. Moss SA, Klein R, Kessler SD, Richie KA. Comparison between ophthalmoscopy and fundus photography in determining severity of diabetic retinopathy. Ophthalmology. 1985;92:62-67.
50. Swanson M. Retinopathy screening in individuals with type 2 diabetes: who, how, how often, and at what cost - an epidemiologic review. Optometry. JAm Optom Assoc. 2005;76:636-646.
51. Kleinstein RN, Roseman JM, Herman WH, et al. Detection of diabetic retinopathy by optometrists. J Am Optom Assoc. 1987;58:879-882.
52. Schachat AP, Hyman L, Leke C, et al. Comparison of diabetic retinopathy detection by clinical examinations and photograph gradings. Arch Ophthalmol. 1993;111: 1064-1070.
53. Emanuele N, Klein R, Moritz T, et al. Comparison of dilated fundus examinations with seven-field stereo fundus photographs in the Veterans Affairs Diabetes Trial. J Diabetes Complications. 2008. doi:10.1016/j.jdiacomp. 2008.02.010
54. Kinyoun JL, Martin DC, Fujimoto WY, Leonetti DL. Ophthalmoscopy versus fundus photographs for detecting and grading diabetic retinopathy. Invest Ophthalmol Vis Sci. 1992;33:1888-1893.
55. Williams GA, Scott IU, Haller JA, et al. Single-field fundus photography for diabetic retinopathy screening. A report by the American Academy of Ophthalmology. Ophthalmology. 2004;111:1055-1062.
56. Williams R, Nussey S, Humphrey R, Thompson G. Assessment of non-mydriatic fundus photography in detection of diabetic retinopathy. Br Med J. 1986;293:1140-1142.
57. Browning DJ, McOwen MD, Bowen RM Jr, O'Marah TL. Comparison of the clinical diagnosis of diabetic macular edema with diagnosis by optical coherence tomography. Ophthalmology. 2004;111:712-715.
58. Scott IU, Bressler BN, Bressler SB, et al. Agreement between clinician and reading center gradings of diabetic retinopathy severity level at baseline in a phase 2 study of intravitreal bevacizumab for diabetic macular edema. Retina. 2008;28:36-40.
59. Kinyoun J, Barton FB, Fishner MR, et al. Detection of diabetic macular edema: ophthalmoscopy versus photography-early treatment diabetic retinopathy study report number 5. Ophthalmology. 1989;96:746-751.
60. McGinn T, Guyatt G, Cook R, Meade M. Diagnosis: measuring agreement beyond chance. In: Guyatt G, Rennie D, eds. User's Guide to the Medical Literature, 1st ed., Chap. 2C. Chicago: AMA Press; 2002.
61. Murgatroyd H, Ellingford A, Cox A, et al. Effect of mydria-sis and different field strategies on digital image screening of diabetic eye disease. Br J Ophthalmol. 2004;88:920-924.
62. Chantelau E, Zwecker M, Weiss H, et al. Fundus polaroid screening for diabetic retinopathy. Is one print per patient enough? Diabetes Care. 1989;12:223-226.
63. Boucher MC, Gresset JA, Angioi K, Olivier S. Effectiveness and safety of screening for diabetic retinopathy with two nonmydriatic digital images compared with the seven standard stereoscopic photographic fields. Can J Ophthalmol. 2003;38:537-542.
64. Beynat J, Charles A, Astruc K, et al. Screening for diabetic retinopathy in a rural French population with a mobile non-mydriatic camera. Diabetes Metab. 2008;35:49-56.
65. The Eye Diseases Prevalence Research Group. The prevalence of diabetic retinopathy among adults in the United States. Arch Ophthalmol. 2004;122:552-563.
66. Perrier M, Boucher MC, Angioi K, et al. Comparison of two, three, and four 45 degrees image fields obtained with the Topcon CRW6 nonmydriatic camera for screening for diabetic retinopathy. Can J Ophthalmol. 2003;38: 569-574.
67. Deb-Joarder N, Germain N, Thuret G, et al. Systematic screening for diabetic retinopathy with a digital fundus camera following pupillary dilatation in a university diabetes department. Diabet Med. 2007;24:303-307.
68. Leese GP, Ahmed S, Newton RW, et al. Use of mobile screening unit for diabetic retinopathy in rural and urban areas. BMJ. 1993;306:187-189.
69. Herbert HM, Jordan K, Flanagan DW. Is screening with digital imaging using one retinal view adequate? Eye. 2003;17:497-500.
70. Taylor DJ, Fisher J, Jacob J, Tooke JE. The use of digital cameras in a mobile retinal screening environment. Diabetes Care. 1999;16:680-686.
71. Peters AL, Davidson MB, Ziel FH. Cost-effective screening for diabetic retinopathy using a nonmydriatic retinal camera in a prepaid health-care setting. Diabetes Care. 1993;16:1193-1195.
72. Maberly D, Cruess AF, Barile G, Slakter J. Digital photographic screening for diabetic retinopathy in the James Bay Cree. Ophthalmic Epidemiol. 2002;9: 169-178.
73. Leske MC, Wu SY, Hyman L, et al. Diabetic retinopathy in a black population-the Barbados eye study. Ophthalmology. 1999;106:1893-1899.
74. O'Hare JP, Hopper A, Madhaven C, et al. Adding retinal photography to screening for diabetic retinopathy: a prospective study in primary care. BMJ. 1996;312:679-682.
75. Scanlon PH, Foy C, Malhotra R, Aldington SJ. The influence of age, duration of diabetes, cataract, and pupil size on image quality in digital photographic retinal screening. Diabetes Care. 2005;28:2448-2453.
76. Maberly D, Morris A, Hay D, et al. A comparison of digital retinal image quality among photographers with different levels of training using a nonmydriatic fundus camera. Ophthalmic Epidemiol. 2004;11:191-197.
77. Lim MCC, Lee SY, Cheng BCL, et al. Diabetic retino-pathy in diabetics referred to a tertiary center from a nationwide screening program. Ann Acad Med Singapore. 2008;37:753-759.
78. Scanlon PH, Carter S, Foy C, et al. An evaluation of the change in activity and workload arising from diabetic ophthalmology referrals following the introduction of a community based digital retinal photographic screening program. Br J Ophthalmol. 2005;89:971-975.
79. Pandit RJ, Taylor R. Mydriasis and glaucoma: exploding the myth. Diabet Med. 2000;17:693-699.
80. Brown JB, Pedula KL, Summers KH. Diabetic retino-pathy. Contemporary prevalence in a well-controlled population. Diabetes Care. 2003;26:2637-2642.
81. Younis N, Broadbent DM, Vora JP, Harding SP. Incidence of sight-threatening retinopathy in patients with type 2 diabetes in the Liverpool Diabetic Eye Study: a cohort study. Lancet. 2003;361:195-200.
82. Lee PP, Meredith LS, Whitcup SM, et al. A comparison of self-reported utilization of ophthalmic care for diabetes in managed care versus fee-for-service. Retina. 1998;18:356-359.
83. The Diabeties Control and Complications Trial Research Group. Color photography vs fluorescein angiography in the detection of diabetic retinopathy in the diabetes control and complications trial. Arch Ophthalmol. 1987;105:1344-1351.
84. Abdel-Ghafar RA, Morris T. Progress towards automated detection and characterization of the optic disc in glaucoma and diabetic retinopathy. Med Inform Internet Med. 2007;32:19-25.
85. Gardner GG, Keating D, Williamson TH, Elliott AT. Automatic detection of diabetic retinopathy using an artificial neural network: a screening tool. Br J Ophthal-mol. 1996;80:940-944.
86. Chaum E, Karnowski TP, Govindasamy VP, et al. Automated diagnosis of retinopathy by content-based image retrieval. Retina. 2008;28:1463-1477.
87. Javitt JC, Aiello LP. Cost-effectiveness of detecting and treating diabetic retinopathy. Ann Intern Med. 1996;124:164-169.
88. Dasbach EJ, Fryback DG, Newcomb PA, et al. Cost-effectiveness of strategies for detecting diabetic retino-pathy. Med Care. 1991;29:20-39.
89. Lairson DR, Pugh JA, Kapadia AS, et al. Cost-effectiveness of alternative methods for diabetic retinopathy screening. Diabetes Care. 1992;15:1369-1377.
90. Fong DS, Gottlieh J, Ferris FL III, Klein R. Understanding the value of diabetic retinopathy screening. Arch Ophthalmol. 2001;119:758-760.
91. Porta M, Bandello F. Diabetic retinopathy. A clinical update. Diabetologia. 2002;45:1617-1634.
92. McCarty CA, Taylor KI, McKay R, et al. Diabetic reti-nopathy: effects of national guidelines on the referral, examination, and treatment practices of ophthalmologists and optometrists. Clin Exp Ophthalmol. 2001;29:52-58.
93. Diabetes Management Program. Improving multiple aspects of diabetes care. NCQA Website. 2009. 4-4-2009.
94. American College of Physicians ADAaAAoO. Screening Guidelines for Diabetic Retinopathy: clinical Guideline. Ann Intern Med. 1992;116:683-685.
95. Kumar N, Goyder E, McKibbin M. The incidence of visual impairment due to diabetic retinopathy in Leeds. Eye. 2006;20:455-459.
96. Javitt JC, Canner JK, Frank RG, et al. Detecting and treating retinopathy in patients with type 1 diabetes mel-litus. Ophthalmology. 1990;97:483-495.
97. Neubauer AS, Kernt M, Haritoglu C, et al. Nonmydria-tic screening for diabetic retinopathy by ultra-widefield scanning laser ophthalmoscopy (Optomap). Graefes Arch Clin Exp Ophthalmol. 2008;246:229-235.